Abstract Restoration of sinus rhythm may result in an improvement of left heart function in patients with atrial fibrillation (AF). Cardiovascular magnetic resonance (CMR) feature tracking (FT) technique may help detect subtle wallmotion abnormalities. Consequently this study aimed to analyse existence and reversibility of subclinical cardiac dysfunction following atrial fibrillation ablation. 28 consecutive patients (mean age 61 years) with paroxysmal AF underwent pulmonary vein isolation. CMR imaging was done 3 (±3) days before and 3.4 (±1.1) months after ablation. Left heart function was determined by performing FT analysis. Statistical analysis included paired student's t test, random effects metaanalysis to assess the cohort's health status and Bland-Altman analysis. 17 patients (61 %) were free from AF at follow-up. Bland-Altman analysis showed good coefficients of variation. Of all 195 parameters, 27 changed (14 %):9 improved significantly (5 %), 12 worsened significantly (6 %), whereas 6 parameters worsened not significantly (3 %). 18 of 120 systolic parameters changed (15 %), 14 worsened (12 %), 4 improved (3 %). In 9 of 75 diastolic parameters, values changed (12 %): 5 improved (7 %) and 4 worsened (5 %). Meta-analysis revealed that our collective's FT values at baseline didn't differ significantly from healthy volunteers' values [Q values of 0.01 (p value 0.921) and 1.499 (p value 0.221)]. AF patients undergoing ablation appear to have near normal cardiac wall motion, which does not improve following successful ablation. Feature tracking analysis is a reliable tool to determine treatment effects but is more likely to show positive findings if the population is unhealthy.
Introduction
Atrial fibrillation (AF) is the most common heart arrhythmia. It is associated with a reduction in quality of life, an increase in disease-related hospitalizations, complications such as stroke and heart failure as well as increased mortality [1] . Hence, treatment of AF is important to lower the rate of these complications.
By isolating the initiating foci of AF, catheter ablation has emerged as an effective and potentially curative treatment option in patients with paroxysmal and persistent AF. Furthermore, reverse atrial remodelling and functional improvement of the left atrium (LA) has been reported after successful ablation procedures [2, 3] . Similarly, restoration of sinus rhythm may result in an improvement of left ventricular (LV) function, especially diastolic function [4] [5] [6] .
Cardiovascular magnetic resonance (CMR) is considered the gold standard in assessing global and regional cardiac function due to its high accuracy and excellent reproducibility [4] . CMR feature tracking, which is a novel post-processing technique similar to echocardiographic speckle tracking, which tracks regional myocardial features throughout the cardiac cycle. With this technique, myocardial strain and velocity measurements can be derived directly from cine images [7] .
Earlier studies have shown that LV ejection fraction (EF) improves in successfully ablated patients with systolic heart failure [8] [9] [10] . However, ejection fraction is a fairly crude parameter of systolic function, and a preserved ejection fraction does not exclude subtle abnormalities of both systolic and diastolic function. Morton et al. [4] summarize that impaired myocardial strain can occur without any detectable changes in LV volumes or function. They furthermore conclude that strain imaging may allow early or subtle detection of abnormalities.
Consequently this study aimed to analyse existence and reversibility of subclinical cardiac dysfunction following AF ablation using CMR feature tracking.
Methods

Study population
This is a prospective single centre study. Consecutive consenting patients with paroxysmal AF refractory to medical management were recruited for catheter ablation. Patients were randomly allocated to undergo pulmonary vein isolation by wide area circumferential ablation (WACA) using radiofrequency energy or ostial cryo-ablation with the cryo-balloon (Cryo). CMR was performed pre-ablation and repeated at 3 months post ablation.
Patients were excluded from recruitment if they showed persistent AF since persistent AF diminishes the quality of MR imaging.
Informed consent to the CMR examinations was obtained from all study patients. The study was approved by a local research ethics committee (UK) and performed in accordance with local data protection laws and regulations.
Control subjects
In order to investigate the health status of our cohort of AF patients with regard to feature tracking parameters, a metaanalysis was performed to compare published healthy volunteers' tracking data to our data at baseline. We searched PubMed throughout January 2013 using the search term ''feature tracking cardiac MRI''. Studies were considered as suitable, if they reported strain values in a healthy cohort. In addition, expert opinions (S.E.P., W.H.S.) were obtained, whether any potentially relevant study was missed. Consequently, the data of these manuscripts were analysed in order to get representative comparison data for a healthy reference collective.
Catheter ablation procedure
The catheter ablation procedure was aimed at electrical isolation of all pulmonary veins (PV) from the LA and has been described in more detail elsewhere [11] . In brief, pulmonary vein isolation (PVI) was achieved by applying either radiofrequency energy (WACA) or freezing (Cryo). For WACA a 3.5 mm irrigated ablation catheter (ThermoCool Celsius Ò or Navistar Ò , Biosense Webster, CA, USA) was used to place contiguous lesions in the LA 1-2 cm from the pulmonary vein ostia to isolate them as ipsilateral pairs. For Cryo, a cryo-balloon (Arctic Front Ò , Medtronic, CA, USA) was inflated in the LA and advanced into the pulmonary vein ostia to isolate each vein at its ostium.
Pulmonary vein isolation was then confirmed by a PV mapping catheter as described previously [12] .
Follow-up
To determine therapeutic success, patients were asked to undergo a cardiac assessment three and 6 months post ablation procedure. After 7 days of ambulatory ECG monitoring at these visits, intervention success was defined as absence of AF or any other atrial tachyarrhythmia lasting C30 s without taking anti-arrhythmic drugs subsequent to a 3 month blanking period, following current guidelines [13] .
Cardiovascular magnetic resonance (CMR) protocol MR imaging was performed on a 1.5T MR-scanner (Achieva Ò , Philips Healthcare, Eindhoven, The Netherlands) using a 32-channel surface coil (Invivo Ò , Orlando, FL, US). Balanced steady-state free precession cine images were acquired in the 2-chamber, 4-chamber and the shortaxis orientations to perform LV function analysis. Typical scan parameters were: TR/TE = 3.2/1.6 ms, SENSE parallel imaging acceleration factor = 1.5-2, slice thickness = 8 mm, slice gap = 2 mm, 1.9 9 2 mm 2 acquired spatial resolution and 30 cardiac phases with 67 % phase sharing. In addition, left atrial cines covering all of the atria (12 slices) were acquired in the same orientation as the short-axis stack using a 5 mm slice thickness and no slice gap.
Image analysis
All images were anonymized and then analyzed by two independent observers (F.C., 4 months standardised training of CMR image analysis and S.E.P., 14 years of CMR experience).
Volumetry
All measurements were assessed using certified software (cvi 42Ó , Circle Cardiovascular Imaging Inc., Calgary, CA). Endocardial and epicardial contours were drawn manually for volumetry of the LV at end-systole and end-diastole on all short-axis slices. To define the most basal image, both observers took into account a content of circumferential myocardium of at least 50 % and a visual control of the short-axis slice position on the 4-chamber view as described previously [5, 14, 15] . Papillary muscles and trabeculations were excluded from LV mass and included in volume calculations. To measure left atrial volumes, contours were drawn with the multiple slice method using the same end-diastolic and end-systolic cardiac phases as determined from LV volumes [16] . PV were excluded at their ostia and the left atrial appendage was excluded at its base. LA volume was automatically calculated from all the included slices. Subsequently, LV and LA function was determined by calculating the ejection fraction with the following formula: ejection fraction = 100*(EDV-ESV)/ EDV [%], where EDV is the end-diastolic and ESV the end-systolic volume.
Feature tracking
Feature tracking analysis was performed using dedicated software (Image-Arena Ó , Version 4.6, TomTec Imaging Systems GmbH, Unterschleissheim, GERMANY). Both epi-and endocardial LV contours were drawn in order to achieve best tracking results. Furthermore, we explored the software's ability to track endoatrial contours in the LA. All contours were tracked semi-automatically in all views. The first slice was used to draw a contour that was then automatically propagated by the software to all slices of the cardiac cycle. Manual correction was performed where the automated tracking visually seemed to be inaccurate. Tracking data were only saved when the contours seemed to be accurate.
The following parameters were obtained: endocardial velocity (reflecting the speed of the endocardium; measured in cm s -1 for radial and longitudinal velocities or deg s -1 for circumferential velocities), strain (reflecting thickening/thinning in short-axis plane and shortening/ lengthening in long-axis plane; indicated in percentage), endocardial strain rate (reflecting speed at which deformation occurs; measured in deformation s -1 ) and torsion (reflecting torsion between the base and the apex of the LV; calculated by dividing the difference of the absolute values of the circumferential velocities of the basal and the apical slice by their distance (4 cm), indicated in deg s -1 cm -1 ). The 2-and 4-chamber views were used to determine all longitudinal parameters. Radial parameters were derived from both short-axis (LV only) and long-axis views (LV and LA). In the short-axis views, three slices were analysed: The nearest slice to the base in which a complete circle of myocardium was trackable throughout the cardiac cycle was selected as the basal slice. The mid-ventricular and apical slice was then chosen with sequential 2 cm gaps towards the apex [17] .
Post-analysis processing included averaging of the values of the software-created 48 tracking points for each slice. Consequently, a curve of mean tracking values over the cardiac cycle was generated. Based on the corresponding time frame of the smallest ventricular area in the mid-ventricular short-axis slice, end-systolic time was determined for all views. To distinguish systolic from diastolic left heart function, the following values were calculated for velocities and strain rates: peak value during systole, time to systolic peak, time to systolic peak-systolic time-ratio, reverse peak value during diastole, diastolic time to reverse peak and diastolic time to diastolic peakdiastolic time-ratio. For strain and torsion values (unimodal shapes) time to peak was divided by the cardiac cycle length.
Statistics All continuous variables were tested for normal distribution using the Kolmogorov-Smirnov tests. Normally distributed variables are presented as mean ± SD. Nonparametric data are presented as median plus inter-quartile range, categorical variables are presented as frequencies and percentages.
Feature tracking values of AF patients after ablation were compared to the pretherapeutic values using the student's t-test for dependent samples in order to assess the effect of AF ablation on feature tracking parameters. A change in parameter was considered as improvement if either the peak value increased, the reverse peak increased in absolute value, the time to peak decreased, or the peak occurred earlier in the cardiac cycle. In analogue, a change in parameter was considered as worsening if either the peak value decreased, the reverse peak decreased in absolute value, the time to peak increased, or the peak occurred later in the cardiac cycle.
We performed a random effects meta-analysis to determine the mean and 95 % confidence intervals for healthy controls from published literature using TomTec's feature tracking software. We then compared baseline strain data derived from our patients at baseline with the effect size for healthy controls derived by meta-analysis using tests for heterogeneity and we report the Q value and corresponding p value.
To assess intra-observer variability, F.C. analysed ten randomly selected pairs of datasets (each containing a baseline and follow-up CMR) twice with 2 months in between analyses. Intra-observer variability data are presented using the Bland and Altman approach determining the mean difference (mean bias) and the limits of agreement [±1.96 SD and the coefficient of variability (SD of mean difference divided by sample mean) is reported].
A p value of less than 0.05 was considered statistically significant. The number and direction of statistically significant effects were used to draw conclusions about presence of true effects. All statistical analyses were performed using dedicated software (SAS Ò Version 9.3; SAS Institute Inc., Cary, NC, US and Comprehensive Meta Analysis Ò Version 2.2; Biostat, Englewood, NJ, US).
Results
Patient population
Patients' were recruited between November 2010 and January 2012. 28 patients underwent CMR imaging both before (mean 3 ± 3 days) and 3 months (3.4 ± 1.1 months) after ablation procedure (56 scans in total). 17 patients were treated with WACA and 11 with Cryo. Median duration of AF before ablation was 51 months (IQR 24-84). AF in all patients was refractory to at least one anti-arrhythmic drug (IQR 1-3, previous use of amiodarone in 8 patients). 12 patients had hypertension (40 %), 3 had previous stroke (10 %) and 3 had a history of ischemic heart disease (10 %). None of the patients were diabetic or had significant valvular disease (defined as Cmoderate regurgitant or stenotic valvular lesion). 17 patients (61 %) were free from AF at 3 months after a single procedure, and this was sustained at 6 months follow-up. 9 successes occurred in the cryoablated group (82 %), 8 in the WACA group (47 %). All recurrent arrhythmia was paroxysmal, and hence all patients were in sinus rhythm at baseline and 3 months scans.
Patient demographics are shown in Table 1 .
Results from intra-observer variability analysis Figure 1 shows Bland-Altman plots for the intra-observer variability analysis. It shows a good agreement between the two repeated measurements with coefficients of variation ranging from 1.7 % (end diastolic volume) to 25.6 % (longitudinal strain).
Cardiac volumes and function
Left ventricular EF was within the normal range and remained stable (57 ± 7 % at baseline vs. 55 ± 7 % at follow-up; p value 0.645) [18] [19] [20] . Mean LA EF was 39 ± 11 %. Mean maximum LA volume was 116 ± 34 mL. 4 subjects had a reduced LV EF of\50 % (14 %).
Feature tracking data
Feature tracking analysis both for LV and LA was feasible in all patients (see Fig. 2 ). Mean heart rate did not change significantly between baseline and follow-up (63 ± 13 vs. 67 ± 15 bpm; p value 0.298). Among all 195 velocity, strain, strain rate and torsion parameters assessed by feature tracking, 27 showed a change (14 %). The following 9 improved significantly (5 % of parameters assessed): time to peak of LA radial velocity, both time to reverse peak and its ratio to diastolic length of LV longitudinal velocity, time to peak of LV apical strain rate, the reverse peaks of LV and LA longitudinal and radial strain rates and both time to peak and its ratio to the cardiac cycle length of LV torsion. The following 12 parameters (6 %) worsened significantly: peak radial velocities of both all LV short axis slices (see Fig. 3 ) and LA long axis view, peak strain of LV mid-ventricular and apical circumferential strain, time to peak ratio of LV long axis and basal short axis strain, time to peak of left atrial longitudinal strain and reverse peaks of all three LV circumferential strain rates. Furthermore, 6 parameters worsened, but not significantly (3 %).
With regard to systolic and diastolic parameters, we could observe changes in 18 of 120 systolic parameters (15 %): 14 worsened (12 %) and 4 improved (3 %). In 9 of 75 diastolic parameters, values showed changes (12 %): 5 improvements (7 %) and 4 worsening (5 %).
Repeat analyses, excluding the 6 patients with impaired LV EF (\50 %) or those patients with unsuccessful ablation showed no significant differences in our findings.
All changes in feature tracking values are summarized in Table 2 .
Meta-analysis
The results from the meta-analysis revealed that mean circumferential and longitudinal strain values of our patient collective at baseline didn't show significant differences to the values derived from healthy subjects in previously published studies [4, 6, 7, [21] [22] [23] ] (see Fig. 4 ). This lack of significant difference was reflected in Q values for circumferential strain of 0.01 (p value 0.921) and for longitudinal strain of 1.499 (p value 0.221). 
Discussion
The main finding of our study is firstly that in this cohort of patients with AF there were no subtle abnormalities of systolic or diastolic function as a plausible underlying aetiology compared to normal controls in the literature. Secondly, elimination of paroxysmal AF by catheter ablation did not have a clear benefit in terms of LV function, albeit in a cohort with mostly normal LV function at baseline. The intra-observer variability suggest that semiautomated analysis using feature tracking software is feasible and robust and does not explain a lack of change due to large variability of outcome measures. In fact, our power calculation suggests, this is unlikely to be due to too small a sample size. The use of semi-automated feature tracking software for detailed analysis of systolic and diastolic function has now been validated in several studies. This paves the way for clinical studies examining its utility in a number of potential areas, such as quantifying mechanical dyssynchrony and patient selection for cardiac resynchronization therapy, assessment of ischaemia and viability, early detection of cardiomyopathies such as hypertrophic cardiomyopathy or arrhythmogenic cardiomyopathy and possibly detection of genotype positive but apparently phenotype negative patients.
The application of this technology to AF is particularly exciting because its aetiology is likely multifactorial and may well involve abnormalities of cardiac function and haemodynamics in a proportion of patients which causes atrial remodelling and thereby promotes AF [24, 25] . The onset of AF may also precipitate heart failure in some patients and increases mortality in those with pre-existing heart failure [26, 27] . A greater understanding of what abnormalities promote AF, how AF adversely affects the heart, and who will respond best to restoration of sinus rhythm will better equip us to prevent AF with upstream therapies and help select patients for curative strategies.
To our knowledge, this is the first study analysing deformation properties of both chambers of the left heart separately for systole and diastole by CMR feature tracking techniques in patients with AF. By studying patients preand post ablation we were able to study the effect of restoring sinus rhythm.
To assess whether feature tracking software allows a reliable analysis in patients with a history of AF, we performed an intra-observer variability analysis. Numerous publications focussing on feature tracking observer variability and inter-study reproducibility have shown that global circumferential and longitudinal strain parameters tended to be the most reproducible. Whilst Augustine et al. indicate coefficients of variation of 2.8 % for circumferential and 12.3 % for longitudinal measurements, Schuster et al. report 13.3 % and 17.3 %, respectively [7, 23] . Our results are in line with these numbers and support the notion that circumferential strain is the most reproducible measure of strain. Longitudinal strain showed a relatively high variation in our analysis. An explanation for this is that the 4-chamber view is possibly affected by the breathdependent position of the diaphragm as suggested by Schuster et al. [22] . Future studies should investigate whether these variations in variability and reproducibility could possibly be caused by physiological variations in heart rate or by differences in imaging resolution.
Results from our analysis of LV and LA function reveal that only minor changes in velocities, strains and strain rates were measurable with the feature tracking technique 3 months after ablation procedures. Since feature tracking is a relatively new tool in image analysis, this study is the first to investigate its clinical applicability in a cohort of patients with paroxysmal AF. Previous studies investigated Although the imaging modalities that underlie the two tracking techniques differ, they both aim to measure the same motion parameters. Whilst a number of studies could detect changes in both atrial and ventricular wall motion after ablation with the use of the speckle tracking technique [28] [29] [30] [31] , we could not observe similar changes of strains or velocities. One possible explanation for this might be that follow-up imaging at only 3 months after ablation procedures was too early to show delayed improvements in motion values. Tops et al. [31] found significant changes in atrial strain and strain rate at 13 ± 7 months follow-up after radiofrequency ablation, whereas Reant et al. [30] assessed LV strain more frequently at 1 and at 6 and 12 months. They showed that LV function improved progressively during the first year and differed significantly from baseline only at the end of follow-up.
Another possible explanation could be found in the differing imaging modalities that underlie the two tracking techniques mentioned: Whilst echocardiography has the advantage of superior temporal resolution, CMR is superior in spatial resolution. In terms of endocardial border tracking during the cardiac cycle both excellent temporal and spatial resolution are desirable. The attempt to increase temporal resolution with maintained spatial resolution in CMR results in prolonged breath-hold time for the patient. However, clinical applicability of extended scan times remains a limitation. Further development of real-time cardiovascular magnetic resonance imaging could provide a solution to the limited frame rate in current CMR techniques compared to echocardiography as previously suggested by Nagel et al. [32] .
In order to explore our patients' health status with regard to cardiac wall motion, we analyzed peak strain values of 266 healthy subjects from six studies. Results from this meta-analysis suggest that mean strain values of our patient cohort at baseline are very similar to the non-AF populations' values. Consequently, we assume that our AF patients did not have altered cardiac deformation before the ablation procedure. This would suggest that a possible post-ablation improvement in cardiac deformation parameters might therefore not have been feasible. Certain characteristics of our cohort may support this assumption: Whilst Reant et al. [30] examined patients with an average duration of AF of 9 years, our patients underwent ablation procedures significantly earlier. Furthermore, our cohort consisted only of patients with paroxysmal AF (self-terminating, usually within 48 h), whereas previous studies included patients with persistent AF (AF episode either lasts longer than 7 days or requires termination) at considerable rates (24-33 %) [28, 31, 33] . Schneider et al. [34] reported lower strain values in subjects with persistent AF as compared to paroxysmal AF and consequently our analysis might be influenced by the exclusion of patients with persistent AF. However, we only included patients with paroxysmal AF who were in sinus rhythm at the time of imaging in order to get best imaging quality. Finally, mean LA EF in our cohort was 39 ± 11 % already at baseline, whereas Jahnke et al. [35] found similar values only after successful ablation procedure (32 ± 17 % at baseline, significant improvement to 41 ± 13 % 3 months after ablation).
The data of the current study must be interpreted in the context of the study design. First, although a power calculation suggests a power of around 90 %, our cohort was limited in size and detection of changes might still have been missed. However, our study design was based on previously reported sample size calculations: Morton et al. [36] suggested a sample size of 29 to detect a change in strain of 5 % with 90 % power and a error of 0.05. Secondly, the follow-up imaging in our study may have been Fig. 4 Comparison of baseline strain values with previously published strain values derived from feature tracking analysis. AF atrial fibrillation, CI confidence interval performed too early to find relevant changes in feature tracking parameters. Future studies should investigate the long-term changes in cardiac wall motion with the help of feature tracking analysis. Finally, our study design did not include a healthy control group. We tried to overcome this by performing a meta-analysis of 266 healthy subjects from 6 published studies. Well-matched control groups are needed in future studies to better understand possible differences in feature tracking values of AF patients and healthy subjects.
In conclusion, feature tracking analysis appears to be a useful and reliable tool to determine treatment effects. Paroxysmal AF patients with grossly preserved LV ejection fraction do not appear to have subtle abnormalities of cardiac wall motion as an underlying aetiology. In this population with normal cardiac function at baseline, there were no subtle improvements in cardiac systolic or diastolic function detected following successful ablation.
